159 related articles for article (PubMed ID: 2920853)
1. Experience relating to pregnancy, lactation, and the after-weaning condition of hyperprolactinemic patients treated with bromocriptine.
Godó G; Koloszár S; Szilágyi I; Daru J; Sas M
Fertil Steril; 1989 Mar; 51(3):529-31. PubMed ID: 2920853
[No Abstract] [Full Text] [Related]
2. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients.
Sabuncu T; Arikan E; Tasan E; Hatemi H
Intern Med; 2001 Sep; 40(9):857-61. PubMed ID: 11579944
[TBL] [Abstract][Full Text] [Related]
4. Bromocriptine for prolactinoma-related dissociative disorder and depression.
Cohen AJ
J Clin Psychopharmacol; 1995 Apr; 15(2):144-5. PubMed ID: 7782492
[No Abstract] [Full Text] [Related]
5. [Bromocriptine monotherapy of a prolactinoma causing erectile dysfunction].
López Cubillana P; Hita Rosino E; Asensio Egea L; Rigabert Montiel M; Hita Villaplana G; Server Pastor G; Server Falgás G
Arch Esp Urol; 1997 Jun; 50(5):526-8. PubMed ID: 9382597
[TBL] [Abstract][Full Text] [Related]
6. Prolactin secretion and menstrual function after long-term bromocriptine treatment.
Rasmussen C; Bergh T; Wide L
Fertil Steril; 1987 Oct; 48(4):550-4. PubMed ID: 3653413
[TBL] [Abstract][Full Text] [Related]
7. Oral and injectable long-lasting bromocriptine preparations in hyperprolactinemia: comparison of their prolactin lowering activity, tolerability and safety.
Merola B; Colao A; Caruso E; Sarnacchiaro F; Briganti F; Lancranjan I; Lombardi G; Schettini G
Gynecol Endocrinol; 1991 Dec; 5(4):267-76. PubMed ID: 1796748
[TBL] [Abstract][Full Text] [Related]
8. Vaginal bromocriptine in hyperprolactinemic patients and puerperal women.
Jasonni VM; Raffelli R; de March A; Frank G; Flamigni C
Acta Obstet Gynecol Scand; 1991; 70(6):493-5. PubMed ID: 1763616
[TBL] [Abstract][Full Text] [Related]
9. Return of menstruation and normalization of prolactin in hyperprolactinemic women with bromocriptine-induced pregnancy.
Rasmussen C; Bergh T; Nillius SJ; Wide L
Fertil Steril; 1985 Jul; 44(1):31-4. PubMed ID: 4007192
[TBL] [Abstract][Full Text] [Related]
10. Terguride as a new anti-hyperprolactinemic agent: characterization in rats and dogs in comparison with bromocriptine.
Mizokawa T; Akai T; Nakada Y; Yamaguchi M; Nakagawa H; Hasan S; Rettig KJ; Wachtel H
Jpn J Pharmacol; 1993 Nov; 63(3):269-78. PubMed ID: 7906316
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and treatment of prolactinomas.
Molitch ME
Adv Intern Med; 1999; 44():117-53. PubMed ID: 9929707
[No Abstract] [Full Text] [Related]
12. [Hyperprolactinemia].
Müller OA; von Werder K
Z Arztl Fortbild (Jena); 1991 Feb; 85(3-4):125-30. PubMed ID: 1676201
[No Abstract] [Full Text] [Related]
13. Normal growth and pubertal development during bromocriptine therapy in two patients with prolactinoma.
Kamel N; Uysal AR; Cesur V; Erdoğan G; Başkal N
Endocr J; 1995 Aug; 42(4):581-6. PubMed ID: 8556068
[TBL] [Abstract][Full Text] [Related]
14. Bromocriptine treatment of prolactinoma restores growth hormone secretion and causes catch-up growth in a prepubertal child.
Sakazume S; Obata K; Takahashi E; Yoshino A; Murakami N; Sakuta R; Murai T; Nagai T
Eur J Pediatr; 2004 Aug; 163(8):472-4. PubMed ID: 15160292
[TBL] [Abstract][Full Text] [Related]
15. [The characteristics of the hormonal interrelationships in a pregnancy stimulated with parlodel].
Ovsiannikov TV; Speranskaia NV; Pshenichnikova TIa; Shchedrina RN; Liashko ES
Akush Ginekol (Mosk); 1989 Dec; (12):8-11. PubMed ID: 2629529
[TBL] [Abstract][Full Text] [Related]
16. Resolution of migraine following bromocriptine treatment of a prolactinoma (pituitary microadenoma).
Hartman N; Voron SC; Hershman JM
Headache; 1995; 35(7):430-1. PubMed ID: 7672963
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic and therapeutic approach to hyperprolactinemia].
Rüedi B
Rev Med Suisse Romande; 1995 May; 115(5):399-401. PubMed ID: 7770687
[No Abstract] [Full Text] [Related]
18. Spontaneous pregnancy after a pregnancy induced by treatment in hyperprolactinemic women.
Yamada M; Miyake A; Koike K; Ikegami H; Aono T; Tanizawa O
Eur J Obstet Gynecol Reprod Biol; 1990; 35(2-3):125-9. PubMed ID: 2335246
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
Glaser B; Nesher Y; Barziliai S
J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
[TBL] [Abstract][Full Text] [Related]
20. [Bromocriptine and methergoline in the inhibition of puerperal lactation].
Abate F; Oliva A; Baviera G; La Spada R; Leonardi R; Bellinvia G
Minerva Ginecol; 1984 Jun; 36(6):303-6. PubMed ID: 6472723
[No Abstract] [Full Text] [Related]
[Next] [New Search]
